A double blind study of pimozide versus chlordiazepoxide in anxiety neuroses. 1976

D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath

Eighteen patients diagnosed as anxiety states were treated under double blind conditions for a four week trial period with pimozide and chlordiazepoxide after randomisation. No significant differences could be demonstrated between chlordiazepoxide and pimozide as far as therapeutic efficacy or toxicity were concerned. Pimozide administered in a single daily dose was as effective as chlordiazepoxide administered in divided daily doses for the relief of anxiety symptoms.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010352 Patient Dropouts Discontinuance of care received by patient(s) due to reasons other than full recovery from the disease. Dropout, Patient,Dropouts, Patient,Patient Dropout
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D002707 Chlordiazepoxide An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal. Methaminodiazepoxide,7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide,7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide,Chlordiazepoxide Hydrobromide,Chlordiazepoxide Hydrochloride,Chlordiazepoxide Monohydrochloride,Chlordiazepoxide Perchlorate,Chlozepid,Elenium,Librium,7 Chloro 2 methylamino 5 phenyl 3H 1,4 benzodiazepine 4 oxide,7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide,Hydrobromide, Chlordiazepoxide,Hydrochloride, Chlordiazepoxide,Monohydrochloride, Chlordiazepoxide,Perchlorate, Chlordiazepoxide
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001008 Anxiety Disorders Persistent and disabling ANXIETY. Anxiety Neuroses,Anxiety States, Neurotic,Neuroses, Anxiety,Anxiety Disorder,Anxiety State, Neurotic,Disorder, Anxiety,Disorders, Anxiety,Neurotic Anxiety State,Neurotic Anxiety States,State, Neurotic Anxiety,States, Neurotic Anxiety

Related Publications

D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
July 1980, Psychopharmacology bulletin,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
March 1982, Pharmacopsychiatria,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
April 1970, Current therapeutic research, clinical and experimental,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
January 2001, The Journal of clinical psychiatry,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
January 1974, Journal of clinical pharmacology,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
October 1964, Obstetrics and gynecology,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
February 1982, The Journal of clinical psychiatry,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
February 1964, Journal of the Medical Association of Georgia,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
December 1986, International journal of clinical pharmacology, therapy, and toxicology,
D R Doongaji, and A S Sheth, and S P Ramesh, and D V Jeste, and P Ravindranath
May 1964, Angiology,
Copied contents to your clipboard!